Skip to main content
SpringerLink
Log in

Insulin resistance in porphyria cutanea tarda

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

It has been reported that patients with porphyria cutanea tarda (PCT) develop carbohydrate (CHO) intolerance and manifest diabetes mellitus (DM) more frequently than the normal population. In order to verify whether this is due to insulin resistance we studied 5 patients with PCT and 5 normal subjects matched for age, sex and weight. In all the patients an evaluation consisted of the glycemic curve and insulin response to an iv glucose tolerance test (IVGTT: 0.33 g/kg) as well as of an evaluation of the circulating monocyte insulin receptors. Blood samples were drawn in the basal state to measure plasma levels of NEFA, glycerol, and intermediate metabolites. The patients with PCT showed normal glucose tolerance which was obtained, however, at the expense of the elevated insulin levels: therefore a condition of insulin resistance was demonstrated in these subjects. An involvement of the lipid metabolism, observed by the raised levels of plasma NEFA and glycerol, was also evident. The insulin binding to circulating monocytes was reduced but not enough to justify the degree of insulin resistance observed. Therefore, it could be hypothesized, in agreement with similar studies, that a postreceptor defect is responsible for the insulin-resistance observed in patients with PCT and that the reduction of insulin receptors is determined by the down regulation in response to elevated insulinemic levels. An alteration of the porphyrin metabolism might be responsible for this disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Harber L.C., Bickers D.R. The prophyrias: Basic science aspects, clinical diagnosis and management. In: Malkinson F., Pearson R. (Eds.), The Yearbook of Dermatology. Yearbook Medical Publishers Inc., Chicago, 1975, p. 9.

    Google Scholar 

  2. Eales I. The prophyrins and the porphyrias. Ann. Rev. Med. 12: 251, 1961.

    Article  CAS  PubMed  Google Scholar 

  3. Rifkind A.B., Gillette P.N., Song C.S. Induction of delta-aminolevulonic acid syntetase by oral contraceptive steroids. J. Clin. Endocrinol. Metab. 30: 330, 1970.

    Article  CAS  PubMed  Google Scholar 

  4. Kushner J.P., Lee G.R. An inherited enzymatic defect in porphyria cutanea tarda. J. Clin. Invest. 58: 1088, 1976.

    Article  Google Scholar 

  5. Walderstrom J., Haeger-Aronsen B. The liver in porphyria cutanea tarda. Ann. Intern. Med. 53: 286, 1960.

    Article  Google Scholar 

  6. Walderstrom J, Haeger-Aronsen B. In: Steinberg A.G., Beams A.G. (Eds.), The porphyrias: A genetic problem. Progress in medical genetics ed. 5. Grune and Stratton, New York, 1967, 58.

  7. Binazzi M., Calandra P., Lisi P., Tomassini M., Frillici S., Lattanzi M., Brunetti P., Bonelli M. Cute e diabete. Giorn. Min. Derm. 111: 427, 1976.

    Google Scholar 

  8. Binazzi M., Lisi P., Calandra P. Studies on the association between skin disorders and diabetes. Ann. It. Derm. Clin. Sper. 32: 211, 1978.

    Google Scholar 

  9. Franks A.G., Pulini M., Bickers D.R., Rayfield E.J., Harber L.C. Carbohydrate metabolism in porphyria cutanea tarda. Am. J. Med. Sci. 277: 163, 1979.

    Article  CAS  PubMed  Google Scholar 

  10. Goerz G., Korda S. Porphyria cutanea tarda (PCT) und Diabetes mellitus. Z. Hautkr. 52: 1165, 1977.

    CAS  PubMed  Google Scholar 

  11. Grossmann M.E., Bickers. D.R., Poh-Fitzpatrick M.B., Deleo V.A., Harber L.C. Porphyria cutanea tarda: Clinical features and laboratory findings in 40 patients. Am. J. Med. 67: 277, 1979.

    Article  Google Scholar 

  12. Lisi P., Santeusanio F., Lombardi G., Compagnucci P. Carbohydrate metabolism in porphyria cutanea tarda. Dermatologica 166: 287, 1983.

    Article  CAS  PubMed  Google Scholar 

  13. Von Kostler E. Porphyria cutanea tarda und Diabetes mellitus. Dermatol. Mon. Schr. 172: 481, 1986.

    CAS  Google Scholar 

  14. Lloyd B., Burrin J., Smythe P., Alberti K.G.M.M. Enzymatic fluorimetric continuous flow assays for blood glucose, lactate, pyruvate, alanine, glycerol and 3-B-OH-butyrate. Clin. Chem. 24: 1724, 1978.

    CAS  PubMed  Google Scholar 

  15. Dole V.P., Meinertz H. Microdetermination of long-chain fatty acids in plasma and tissues. J. Biol. Chem. 235: 2595, 1960.

    CAS  PubMed  Google Scholar 

  16. Yalow R.S., Berson S.A. Immunoassay of endogenous plasma insulin in man. J. Clin. Invest. 39: 1159, 1960.

    Article  Google Scholar 

  17. Herbert V., Lav K.S., GottliebTG.W., Bleicher S.J. Coated charcoal immunoassay of insulin. J. Clin. Endocrinol. Metab. 25: 1375, 1965.

    Article  CAS  PubMed  Google Scholar 

  18. Boyum A. A one stage procedure for isolation of granulocytes and lymphocytes from human blood. Scand. J. Clin. Lab. Invest. 97: 21, 1968.

    Google Scholar 

  19. Yam L.Li C., Crosby W. Cytochemical identification of monocytes and granulocytes. Am. J. Clin. Pathol. 55: 283, 1971.

    CAS  PubMed  Google Scholar 

  20. Scatchard G. The attraction of proteins for small molecules and ions. Ann. NY Acad. Sci. 51: 660, 1949.

    Article  CAS  Google Scholar 

  21. De Meyts P., Roth J. Cooperativity in ligand binding: A new graphic analysis. Biochem. Biophys. Res. Commun. 66: 1118, 1975.

    Google Scholar 

  22. Kolterman O.G., Insel J., Saekow M., Olefsky J.M. Mechanisms of insulin resistance in human obesity: Evidence for receptor and postreceptor defects. J. Clin. Invest. 65: 1272, 1980.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Muggeo M., Bar R.S., Roth J., Cahn C.R., Gorden P. Insulin resistance of acromegaly: Evidence for alterations in the insulin receptors on circulating monocytes. J. Clin. Endocrinol. Metab. 48: 17, 1979.

    Article  CAS  PubMed  Google Scholar 

  24. Olefsky J.M., Kolterman O.G. Mechanism of insulin resistance in obesity and noninsulin-dependent (Type II) diabetes. Am. J. Med. 70: 151, 1981.

    Article  CAS  PubMed  Google Scholar 

  25. De Fronzo R., Ferrannini E., Koivisto V. New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus. Am. J. Med.: 52, 1983.

  26. Olefsky J.M. Effect of dexamethasone on insulin binding, glucose transport and glucose oxidation of isolated rat adipocytes. J. Clin. Invest. 56: 1499, 1975.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Rizza R., Mandarino L., Gerich J. Mechanisms of insulin resistance in man: Assessment using the insulin dose-response curve in conjunction with insulin receptor binding. Am. J. Med. 70: 169, 1981.

    Article  CAS  PubMed  Google Scholar 

  28. Calafiore R., Scionti L., Calcinaro F., Pietropaolo M., Basta G., Santeusanio F. Glucocorticoidi e resistenza insulinica: Effetti di desametasone, betametasone e triamcinolone sui recettori insulinici di soggetti normali. Rec. Progr. Med. 76: 22, 1985.

    CAS  Google Scholar 

  29. Samaan N.A., Stone D.B., Eckhardt R.D. Serum glucose, insulin, and growth hormone in chronic hepatic cirrhosis. Arch. Intern. Med. 124: 149, 1969.

    Article  CAS  PubMed  Google Scholar 

  30. Trischitta V., Brunetti A., Benzi L., Marchetti P., Vigneri R. Characterization of insulin degrading activity in subcellular fractions of human monocytes. Diab.Nutr. Metab. 1: 71, 1988.

    Google Scholar 

  31. Collins J.R., Lacy W.W., Stiel J.N., Crofford O.B. Glucose tolerance and insulin resistance in patients with liver disease. II. A study of etiologic factors and evaluation of insulin actions. Arch. Intern. Med. 126: 608, 1970.

    Article  CAS  PubMed  Google Scholar 

  32. Dupré J., Lubetzki J., Warnet A. Etude de la tolerance au glucose, de I’insulino-secretion et de la sensibilité endogène au cours de affections alcooliques du fois. Le Diabéte 22: 143, 1974.

    Google Scholar 

  33. Greco A.V., Rebuzzi A.G., Altomante L., Manna R., Bertoli A., Ghirlanda G. Glucose, insulin and somatostatin infusion for the determination of insulin resistance in liver cirrhosis. Horm. Metab. Res. 11: 547, 1979.

    Article  CAS  PubMed  Google Scholar 

  34. Greco A.V., Bertoli A., Ghirlanda G., Manna P., Altomante L., Rebuzzi A.G. Insulin resistance in liver cirrhosis: Decreased insulin binding to circulating monocytes. Horm. Metab. Res. 12: 577, 1980.

    Article  CAS  PubMed  Google Scholar 

  35. Proietto J., Alford F.B., Dudley F.J. The mechanism of the carbohydrate intolerance of cirrhosis. J. Clin. Endocrinol. Metab. 51: 1030, 1981.

    Article  Google Scholar 

  36. Bar R.S., Muggeo M., Roth C.J., Kahn C.R., Havrankova J., Imperato-McGinley J. Insulin resistance, acanthosis nigricans, and normal insulin receptors in a young woman: evidence for a postreceptor defect. J. Clin. Endocrinol. Metab. 47: 620, 1978.

    Article  CAS  PubMed  Google Scholar 

  37. Kahn C.R., Flier J.S., Bar R.S., Archer J.A., Gorden P., Martin M.M., Roth J. The syndromes of insulin resistance and acanthosis nigricans: insulin receptor disorders in man. N. Engl. J. Med. 294: 739, 1976.

    Article  CAS  PubMed  Google Scholar 

  38. Bar R.S., Levis W.R., Rechter M.M., Harrison L.C., Siebert C., Podskalny J., Roth J., Muggeo M. Extreme insulin resistance in ataxia teleangectasia. Defect in affinity of insulin receptors. N. Engl. J. Med. 298: 1164, 1978.

    Article  CAS  PubMed  Google Scholar 

  39. Perlroth M.G., Tschudy D.P., Waxman A., Odell W.D. Abnormalities of growth hormone in acute intermittent porphyria. Metabolism 16: 87, 1967.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituti di Patologia Speciale Medica e di Clinica Dermatologica e Venereologica, Università di Perugia, Via E. dal Pozzo, 06100, Perugia, Italy

    F. Calcinaro M.D., G. Basta, C. Cruciani, M. Pietropaolo, F. Santeusanio, A. Falorni Jr. & R. Calafiore

  2. Clinica Dermatologica e Venereologica, Università di Perugia, 06100, Perugia, Italy

    P. Lisi

Authors
  1. F. Calcinaro M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Basta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Lisi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Cruciani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Pietropaolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. Santeusanio
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. Falorni Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R. Calafiore
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Calcinaro, F., Basta, G., Lisi, P. et al. Insulin resistance in porphyria cutanea tarda. J Endocrinol Invest 12, 393–399 (1989). https://doi.org/10.1007/BF03350708

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350708

Key-words

Search

Navigation